“THE CLINICAL SIGNIFICANCE OF INTERLEUKIN-4 IN SYSTEMIC SCLERODERMA”. Spectrum Journal of Innovation, Reforms and Development 27 (May 24, 2024): 51–58. Accessed January 30, 2026. https://sjird.journalspark.org/index.php/sjird/article/view/1033.